- Home
- BGT vs TKNO Comparison
BGT vs TKNO Comparison
Compare BGT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGT
- TKNO
- Stock Information
- Founded
- BGT 2004
- TKNO 1996
- Country
- BGT United States
- TKNO United States
- Employees
- BGT N/A
- TKNO N/A
- Industry
- BGT Trusts Except Educational Religious and Charitable
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- BGT Finance
- TKNO Health Care
- Exchange
- BGT Nasdaq
- TKNO Nasdaq
- Market Cap
- BGT 320.3M
- TKNO 340.9M
- IPO Year
- BGT N/A
- TKNO 2021
- Fundamental
- Price
- BGT $12.24
- TKNO $5.33
- Analyst Decision
- BGT
- TKNO
- Analyst Count
- BGT 0
- TKNO 0
- Target Price
- BGT N/A
- TKNO N/A
- AVG Volume (30 Days)
- BGT 107.2K
- TKNO 370.4K
- Earning Date
- BGT 01-01-0001
- TKNO 11-06-2025
- Dividend Yield
- BGT 10.77%
- TKNO N/A
- EPS Growth
- BGT N/A
- TKNO N/A
- EPS
- BGT N/A
- TKNO N/A
- Revenue
- BGT N/A
- TKNO $38,923,000.00
- Revenue This Year
- BGT N/A
- TKNO $9.52
- Revenue Next Year
- BGT N/A
- TKNO $15.20
- P/E Ratio
- BGT N/A
- TKNO N/A
- Revenue Growth
- BGT N/A
- TKNO 11.40
- 52 Week Low
- BGT $10.89
- TKNO $3.94
- 52 Week High
- BGT $13.42
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- BGT 47.34
- TKNO 51.65
- Support Level
- BGT $12.02
- TKNO $5.20
- Resistance Level
- BGT $12.25
- TKNO $6.68
- Average True Range (ATR)
- BGT 0.09
- TKNO 0.61
- MACD
- BGT 0.01
- TKNO -0.04
- Stochastic Oscillator
- BGT 56.25
- TKNO 36.29
About BGT BlackRock Floating Rate Income Trust
Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.